AKRO – akero therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Akero Therapeutics to Present at the Jefferies London Healthcare Conference
Akero Therapeutics Advances in MASH Treatment Trials [Yahoo! Finance]
Akero Therapeutics, Inc. (NASDAQ: AKRO) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $50.00 price target on the stock.
Akero Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update
Akero Therapeutics to Present Data Reinforcing the Efficacy of Efruxifermin at the 75th Annual AASLD The Liver Meeting® 2024
Form SC 13G/A Akero Therapeutics, Inc. Filed by: JANUS HENDERSON GROUP PLC
Form SC 13G/A Akero Therapeutics, Inc. Filed by: PRICE T ROWE ASSOCIATES INC /MD/
Form SC 13G/A Akero Therapeutics, Inc. Filed by: RTW INVESTMENTS, LP
Form SC 13G/A Akero Therapeutics, Inc. Filed by: ALKEON CAPITAL MANAGEMENT LLC
Form 4 Akero Therapeutics, Inc. For: Nov 06 Filed by: Yale Catriona
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.